IFI-M · PK Sequential Integration Series

Specimen SS-F-M2-03700 // MULTI-AXIS · IFI-M

PK Sequential Integration Series IV-BL-A

Brassica nigra

Black Mustard

Tier IVPK Sequential Integration Series

Target Trait

2.95×

fold-change

Sharp+Kokumi sequential pathway fold-change

Technical Specifications

SKU

SS-F-M2-03700

Genomic Edits

9

GC Content

45.1%

Construct Length

4,644 bp

Promoter System

CaMV 35S / Ubiquitin

Expression System

Biolistic transformation

Host Strain

Particle Gun

Receptor Target

TRPA1 + CaSR

IFI Score

295

Pathway Edits

  • TRPA1 pathway primary gene cluster overexpression for sharp axis activation
  • CaSR pathway primary gene cluster overexpression for kokumi axis activation
  • Bidirectional promoter system for synchronized P+K dual-axis co-expression
  • Metabolic flux partitioning between IFI-P and IFI-K pathway branches via carbon flow optimization
  • Transcription factor co-binding site engineering for Sharp-Kokumi combinatorial gene regulation
  • Cross-pathway feedback inhibition circuit removal for P+K simultaneous accumulation
  • Cofactor balance optimization for P+K dual-pathway operation
  • Protein scaffold engineering for P+K enzyme co-localization

Key Interventions

Dual-receptor co-activation via synchronized TRPA1 and CaSR pathway engineeringMetabolic flux partitioning strategy enabling simultaneous sharp and kokumi accumulation without competing pathway suppressionSequential construct stacking for PK multi-axis integrationBiolistic co-bombardment of multi-axis transgene cassettes for high-copy integration events

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV PK dual-axis sequential integration platform for food ingredient applications requiring verified combined sharp+kokumi sensory character. Suitable for multi-modal flavor architecture, premium ingredient certification, and receptor-confirmed IFI multi-axis profiling.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?